A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Novartis
Novartis
Varian, a Siemens Healthineers Company
Hoffmann-La Roche
Eli Lilly and Company
AstraZeneca
AstraZeneca
Boehringer Ingelheim
BeOne Medicines
Boehringer Ingelheim
IDEAYA Biosciences
Revolution Medicines, Inc.
Genmab
Intuitive Surgical
Actuate Therapeutics Inc.
Guardant Health, Inc.
Pfizer
Merck Sharp & Dohme LLC
Pfizer
Arcus Biosciences, Inc.
Mirati Therapeutics Inc.
Delfi Diagnostics Inc.
Novartis
Seagen Inc.
AstraZeneca
Pfizer
AstraZeneca
AstraZeneca
Amgen
Replimune, Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Carevive Systems, Inc.
Creo Medical Limited
AstraZeneca
AstraZeneca
Regeneron Pharmaceuticals
AstraZeneca
Seagen Inc.
AgonOx, Inc.
AstraZeneca
Pierre Fabre Medicament
Eli Lilly and Company
Novartis
TILT Biotherapeutics Ltd.
Inhibrx Biosciences, Inc
Incyte Corporation
Complement Theory Inc.
Black Diamond Therapeutics, Inc.
Integro Theranostics